PGC-1α overexpression was shown to interfere with muscle atrophy induced by activation of the TWEAK-Fn14 pathway [85] and to improve cancer-induced muscle wasting in tumor-bearing mice [73, 86], although contrasting data were previously reported [87]. Here, TNFSF12 is linked to cancer.